Ocuphire Pharma, Inc. (OCUP) Misses Q1 EPS by 12c

Ocuphire Pharma, Inc. (NASDAQ: OCUP) reported Q1 EPS of ($0.28), $0.12 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.75 million versus the consensus estimate of $3.68 million.

For earnings history and earnings-related data on Ocuphire Pharma, Inc. (OCUP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c